Neuroscience
Les inhibiteurs en neurosciences sont des composés conçus pour moduler l'activité de protéines, d'enzymes ou de récepteurs spécifiques au sein du système nerveux. Ces inhibiteurs sont cruciaux pour étudier les mécanismes moléculaires sous-jacents au fonctionnement neuronal, à la transmission synaptique et aux maladies neurodégénératives. En ciblant les récepteurs des neurotransmetteurs, les canaux ioniques et les voies de signalisation, les inhibiteurs en neurosciences facilitent l'exploration du fonctionnement cérébral et le développement de stratégies thérapeutiques pour des troubles neurologiques tels que la maladie d'Alzheimer, de Parkinson et l'épilepsie. Chez CymitQuimica, nous offrons une gamme complète d'inhibiteurs en neurosciences de haute qualité pour soutenir vos recherches en neurobiologie, neuropharmacologie et sciences cognitives.
Sous-catégories appartenant à la catégorie "Neuroscience"
- récepteur 5-HT(1.025 produits)
- ACK(1 produits)
- AChR(647 produits)
- ATP Citrate Lyase(17 produits)
- Récepteur adrénergique(3.023 produits)
- BACE(37 produits)
- Bêta-amyloïde(228 produits)
- CaMK(73 produits)
- COX(600 produits)
- Récepteur de la dopamine(445 produits)
- Récepteur GABA(373 produits)
- Gamma-sécrétase(61 produits)
- GluR(265 produits)
- GlyT(26 produits)
- Récepteur de l'histamine(385 produits)
- LRRK2(43 produits)
- Récepteur de la mélatonine(26 produits)
- NMDAR(10 produits)
- Récepteur OX(41 produits)
- Récepteur opioïde(327 produits)
Affichez 12 plus de sous-catégories
5612 produits trouvés pour "Neuroscience"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
AMPA receptor modulator-1
CAS :AMPA receptor modulator-1 can be activated by glutamate, thereby modulating ion channels.
Formule :C16H11ClF3NO2Degré de pureté :99.93%Couleur et forme :SolidMasse moléculaire :341.71R-(+)-EU-1180-453
CAS :R-(+)-EU-1180-453 is a novel GluN2C/D selective NMDAR-positive modulator for the study of neurological disorders.Formule :C22H21FN2O3Degré de pureté :99.63%Couleur et forme :SolidMasse moléculaire :380.41TZ3O
CAS :TZ3O is an anticholinergic compound with neuroprotective activity.TZ3O ameliorates memory impairment in Scopolamine-induced Alzheimer's type model in rats.Formule :C18H13NO4SDegré de pureté :99.84%Couleur et forme :SolidMasse moléculaire :339.37BuChE-IN-TM-10
CAS :TM-10: Potent BuChE inhibitor, IC50 8.9 nM, disaggregates Aβ, antioxidant, BBB penetrant, may treat Alzheimer's.Formule :C32H38N2O3Degré de pureté :99.54%Couleur et forme :SolidMasse moléculaire :498.66Didesmethyl cariprazine
CAS :Didesmethyl cariprazine, Cariprazine's active metabolite, treats schizophrenia/bipolar with D3/D2 affinity; half-life 1-3 weeks.Formule :C19H28Cl2N4ODegré de pureté :99.52%Couleur et forme :SolidMasse moléculaire :399.36PXS-5120A
CAS :PXS-5120A is an irreversible fluoroallylamine Lysyl Oxidase-like 2/3 (LOXL2/3) inhibitor with anti-fibrotic activity.Formule :C22H25ClFN3O4SDegré de pureté :97.02%Couleur et forme :SolidMasse moléculaire :481.97Ref: TM-T12584
1mg205,00€2mg293,00€5mg462,00€1mL*10mM (DMSO)502,00€10mg612,00€25mg893,00€50mg1.224,00€100mg1.639,00€SB-616234-A
CAS :SB-616234-A is a selective and orally bioavailable antagonist of 5-HT1B receptor, with anxiolytic and antidepressant activity.Formule :C32H36ClN5O3Degré de pureté :99.72%Couleur et forme :SolidMasse moléculaire :574.11BMS-986176
CAS :AAK1-IN-1 is a highly selective and potent inhibitor of adaptor associated kinase 1 (AAK1, IC50 = 2 nM).
Formule :C19H23F4N3ODegré de pureté :98.58% - 98.7%Couleur et forme :SolidMasse moléculaire :385.4MDR-1339
CAS :MDR-1339 is a blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.Formule :C20H22O4Degré de pureté :98.57%Couleur et forme :SolidMasse moléculaire :326.39Lumateperone
CAS :Lumateperone (ITI 722) is a 5HT2A receptor antagonist and a dopamine receptor phosphoprotein modulator (DPPM).Formule :C24H28FN3ODegré de pureté :99.68% - 99.91%Couleur et forme :SolidMasse moléculaire :393.5PXS-5153A
CAS :PXS-5153A rapidly inhibits lysyl oxidase 2/3 enzymes, blocks activity in 15 mins, and reduces fibrosis.Formule :C20H25Cl2FN4O2SDegré de pureté :99.58%Couleur et forme :SolidMasse moléculaire :475.41QP5020
CAS :QP5020 is a QPCTL inhibitor with an IC50 value of 15 nM, demonstrating antitumor efficacy.Formule :C20H19FN6Masse moléculaire :362.40PF-06442609
CAS :PF-06442609 is an orally active γ-secretase modulator with an IC50 value of 6 nM for Aβ42. It exhibits good CNS permeability.Formule :C24H24F4N4O3Masse moléculaire :492.47MAO-B-IN-6
MAO-B-IN-6 is a selective, potent, orally active MAO-B inhibitor (IC50: 0.019 μM). MAO-B-IN-6 is superior to Safinamide both in vitro and in vivo.Couleur et forme :SolidRemlifanserin
CAS :Remlifanserin is a potent inverse agonist of the serotonin receptor (5-HT2A).Formule :C24H29F2N3O2Couleur et forme :SolidMasse moléculaire :429.50AChE-IN-5
AChE-IN-5: oral, crosses blood-brain barrier, targets AChE/5-HT1A/SERT, potent with 2.29 nM IC50.Formule :C38H45N5OCouleur et forme :SolidMasse moléculaire :587.8Azotomycin
CAS :Azotomycin is an antagonist of L-glutamine and may be used as an immunosuppressant.Formule :C17H23N7O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :453.41PF470
CAS :PF470 (PF-06297470) is a negative allosteric modulator of the metabotropic glutamate receptor 5 (mGluR5), which demonstrated significant therapeutic effects in Parkinson's disease models. However, its clinical development was halted due to potential issues identified in toxicological studies.Formule :C18H16N6OCouleur et forme :SolidMasse moléculaire :332.36SB 243213 hydrochloride
CAS :SB 243213 hydrochloride is an orally active, selective and high-affinity antagonist of 5-hydroxytryptamine (5-HT)2C receptor(pKi of 9.37 and a pKb of 9.8).ItFormule :C22H20ClF3N4O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :464.87MAO-A inhibitor 1
CAS :MAO-A Inhibitor 1 (compound VIII) acts as a MAO-A inhibitor and exhibits an IC50 value of 100 μM [1].Formule :C14H12O4Couleur et forme :SolidMasse moléculaire :244.24LRRK2-IN-20
CAS :LRRK2-IN-20 (EX. 4.64) is a selective inhibitor of LRRK2 with a potency of pIC50 at 0.7921 nM. This compound is applicable in research studies focused on Parkinson's Disease (PD).Formule :C24H32ClN7OCouleur et forme :SolidMasse moléculaire :470.01Refisolone
CAS :Refisolone is an antagonist of the GABAA receptor.Formule :C18H24O3Couleur et forme :SolidMasse moléculaire :288.381BACE1-IN-8
BACE1-IN-8 is a potent inhibitor of BACE1 (β-site APP lyase 1) (IC50: 3.9 μM).Formule :C29H45N5O7Couleur et forme :SolidMasse moléculaire :575.7Amyloid-β-IN-3
CAS :Amyloid-β-IN-3 (EX.113) is a selective inhibitor of γ-secretase. It demonstrates inhibitory activity on Aβ42 secretion in H4 cells, with an EC50 value of 148 nM. By modulating the catalytic activity of γ-secretase, Amyloid-β-IN-3 decreases Aβ42 production, thereby alleviating neurotoxicity caused by Aβ deposition. It holds potential for Alzheimer's disease (AD) research.Formule :C22H21F2N3O2Couleur et forme :SolidMasse moléculaire :397.42Etoperidone
CAS :Etoperidone is an antidepressant that acts as an orally active reuptake inhibitor for serotonin (serotonin) and noradrenaline (nor-adrenaline). It demonstrates specific binding affinities (Kd) for several receptors: 36 nM at the 5-HT2 receptor, 38 nM at the α1-adrenergic receptor (α1-adrenergic receptor), 85 nM at the 5-HT1A receptor, and 570 nM at the α2-adrenergic receptor (α2-adrenergic receptor).Formule :C19H28ClN5OCouleur et forme :SolidMasse moléculaire :377.91Tebideutorexant
CAS :Tebideutorexant, an orexin-1 receptor antagonist, shows anti-panic effects in rodents and humans, providing a tool for stress response and psychiatric research.Formule :C23H16D2F4N4O2Degré de pureté :98.89%Couleur et forme :SolidMasse moléculaire :460.42AChE-IN-8
AChE-IN-8 (Compound 19), potent acetylcholinesterase blocker; IC50 = 1.95 μM; potential Alzheimer's treatment.Formule :C20H22N4O2SCouleur et forme :SolidMasse moléculaire :382.48AChE-IN-79
AChE-IN-79 (compound 3i) is an acetylcholinesterase inhibitor with an IC50 of 2.7 µM, suitable for studies related to Alzheimer's disease.Formule :C29H27NO6SCouleur et forme :SolidMasse moléculaire :517.59Befiradol hydrochloride
CAS :Befiradol HCl (NLX-112) is a selective 5-HT1A receptor agonist with anxiolytic effects and prevents ATXN3 aggregation.Formule :C20H23Cl2F2N3ODegré de pureté :99.64%Couleur et forme :SolidMasse moléculaire :430.32TP003
CAS :TP003 is a novel non-selective GABAA receptor benzodiazepine site agonist with affinity for α1β2gam2, α2β3gam2, α3β3gam2, α5β2gam2, EC50 of 20.3, 10.6, 3.24, 5.
Formule :C23H16F3N3ODegré de pureté :99.17%Couleur et forme :SolidMasse moléculaire :407.39Tipindole
CAS :Tipindole is a serotonin antagonist utilized in research related to depression.Formule :C16H20N2O2SCouleur et forme :SolidMasse moléculaire :304.41SRI-31255
CAS :SRI-31255 is an orally active LRRK2 inhibitor, with IC50 values of 520 nM for human wild-type (WT) and 427 nM for the G2019S mutant. It inhibits kinase activity by binding to the ATP-binding pocket of LRRK2, providing neuroprotective effects. SRI-31255 serves as a lead compound for developing LRRK2-targeted therapies for Parkinson’s disease research.Formule :C15H14N4Couleur et forme :SolidMasse moléculaire :250.30LRRK2-IN-16
CAS :LRRK2-IN-16 (compound 25) is an inhibitor of the LRRK2 kinase with an IC50 value of less than 5 μM. It is applicable for research in neurodegenerative and autoimmune diseases.Formule :C18H19N5OSCouleur et forme :SolidMasse moléculaire :353.441Fletazepam
CAS :Fletazepam, a benzodiazepine derivative, exhibits sedative, anti-anxiety, and muscle-relaxant properties. It is utilized in neurological research.Formule :C17H13ClF4N2Couleur et forme :SolidMasse moléculaire :356.74BACE1-IN-5
CAS :BACE1-IN-5 inhibits BACE1 (IC50: 9.1 nM) & Aβ production (IC50: 0.82 nM), enhances hERG inhibition & P-gp efflux.Formule :C18H16F5N5O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :461.41Glutaminyl Cyclase Inhibitor 3
CAS :Designed anti-Alzheimer’s compound; potent Glutaminyl Cyclase inhibitor; IC50 at 4.5 nM; reduces brain Aβ; improves cognition.Formule :C24H32N6O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :468.61(R,R)-LRRK2-IN-7
CAS :(R,R)-LRRK2-IN-7 is an isomer of LRRK2-IN-7, a potent and selective LRRK2 kinase inhibitor with CNS penetrance. It exhibits an IC50 of 0.9 nM and demonstrates over 1000-fold selectivity compared to other kinases, ion channels, and CYP enzymes.Formule :C24H26N6OMasse moléculaire :414.50MAO-B-IN-34
CAS :MAO-B-IN-34 (compound 3d) is an inhibitor of monoamine oxidase B.Formule :C15H9Cl2NO3Couleur et forme :SolidMasse moléculaire :322.14LRRK2-IN-3
CAS :LRRK2-IN-3: potent, selective oral LRRK2 blocker, BBB-penetrant, IC50 of 0.6 nM in hPBMCs, for Parkinson's research.Formule :C25H29ClF2N6O2Couleur et forme :SolidMasse moléculaire :518.998 Hydroxy PIPAT oxalate
CAS :8 Hydroxy PIPAT oxalate is a selective 5-HT1A receptor agonist that enhances the spontaneous release of histamine by promoting the degranulation of mast cells in guinea pig and human intestinal preparations. By activating the serotonin signaling pathway, this compound demonstrates potential in regulating gastrointestinal functions and offers insight into the management and suppression of functional gastrointestinal disorders such as irritable bowel syndrome. Its effects in increasing histamine release could play a crucial role in gastrointestinal regulation.Formule :C18H24INO5Couleur et forme :SolidMasse moléculaire :461.29VU6016235
CAS :VU6016235 is a structurally unique, orally available, and highly selective tricyclic M4 muscarinic acetylcholine receptor positive allosteric modulator.Formule :C21H22N4OSCouleur et forme :SolidMasse moléculaire :378.49LRRK2-IN-14
CAS :LRRK2-IN-14 (Compound 8), an orally active inhibitor of LRRK2, exhibits an IC 50 of 6.3 nM against LRRK2(G2019S) cell activity and demonstrates inhibitory effects on hERG with an IC 50 of 22 μM. Additionally, LRRK2-IN-14 is permeable to the blood-brain barrier [1].Formule :C17H18F3N5O2Couleur et forme :SolidMasse moléculaire :381.35LRRK2-IN-13
CAS :LRRK2-IN-13 (Compound 13), with an IC50 value of 0.57 nM, serves as an inhibitor of LRRK2 and exhibits properties that allow it to penetrate the brain [1].Formule :C19H19ClN8O2Couleur et forme :SolidMasse moléculaire :426.86(E)-CHBO4
CAS :(E)-CHBO4 is an MAO-B inhibitor with an IC50 value of 0.023 μM, making it a potential candidate for research into Parkinson's disease treatment.Formule :C15H10BrFOCouleur et forme :SolidMasse moléculaire :305.142CGS-9895
CAS :CGS-9895 is a GABA antagonist that operates by interacting with the benzodiazepine binding site on GABA receptors containing the γ subunit (ag).Formule :C17H13N3O2Couleur et forme :SolidMasse moléculaire :291.304AChE/BChE-IN-19
CAS :AChE/BChE-IN-19 (compound 12) is a nicotinic hydrazine derivative that acts as an inhibitor of AChE (IC50=21.45 nM) and BChE (IC50=18.42 nM), and it is applicable in Alzheimer's disease research.Formule :C26H22N4O3Masse moléculaire :438.48ZK 93426 hydrochloride
CAS :benzodiazepine receptor antagonist,competitiveFormule :C18H21ClN2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :348.825-HT2A receptor agonist-7
CAS :5-HT2A receptor agonist-7 (517) functions as a modulator of the 5-HT2A receptor, with an EC50 value of less than 100 nM.Formule :C12H11F2N3Couleur et forme :SolidMasse moléculaire :235.233K203
K203 is a potent tabun-inhibited AChE reactivator and is an important antidote to organophosphorus poisoning.Formule :C16H18Br2N4O2Couleur et forme :SolidMasse moléculaire :458.15AChE-IN-63
CAS :AChE-IN-63 (Compound 5AD) serves as a selective inhibitor of hAChE, exhibiting an IC 50 value of 0.103 μM. Moreover, it inhibits hBChE and hBACE-1 with IC 50 values of 10 μM and 1.342 μM, respectively. AChE-IN-63 is effective in inhibiting Aβ aggregation and preventing the formation and deposition of Aβ1-42. It can effectively penetrate the blood-brain barrier and is orally bioavailable. This compound is primarily utilized in research related to Alzheimer's disease [1].Formule :C18H19N5OCouleur et forme :SolidMasse moléculaire :321.38
